Neogen Announces the Appointment of New Board Member
Neogen (NASDAQ: NEOG) has announced the appointment of Thierry Bernard as a new director to its Board, effective November 1, 2024. Bernard, the current CEO of QIAGEN N.V., brings extensive experience in science and technologies relevant to Neogen's markets. Jim Borel, Neogen's Board Chair, expressed confidence that Bernard's expertise will provide significant value during the company's continued growth.
Bernard has been CEO of QIAGEN since March 2020, after joining the company in 2015. His prior experience includes 15 years at bioMérieux SA, where he held various senior roles, including Corporate Vice President of Global Commercial Operations, Investor Relations, and the Greater China Region. This appointment aligns with Neogen's commitment to enhancing global food security.
Neogen (NASDAQ: NEOG) ha annunciato la nomina di Thierry Bernard come nuovo direttore del suo Consiglio di Amministrazione, con effetto dal 1 novembre 2024. Bernard, attuale CEO di QIAGEN N.V., porta con sé una vasta esperienza nel campo delle scienze e delle tecnologie pertinenti ai mercati di Neogen. Jim Borel, presidente del Consiglio di Amministrazione di Neogen, ha espresso fiducia nel fatto che l'esperienza di Bernard apporterà un valore significativo durante la continua crescita dell'azienda.
Bernard è CEO di QIAGEN dal marzo 2020, dopo aver iniziato a lavorare in azienda nel 2015. La sua esperienza precedente include 15 anni presso bioMérieux SA, dove ha ricoperto vari ruoli di alto livello, tra cui Vice Presidente Globale delle Operazioni Commerciali, Relazioni con gli Investitori e la Regione della Cina continentale. Questa nomina è in linea con l'impegno di Neogen nel migliorare la sicurezza alimentare globale.
Neogen (NASDAQ: NEOG) ha anunciado el nombramiento de Thierry Bernard como nuevo director de su Junta, con efecto a partir del 1 de noviembre de 2024. Bernard, actual CEO de QIAGEN N.V., aporta una amplia experiencia en ciencias y tecnologías relevantes para los mercados de Neogen. Jim Borel, presidente de la Junta de Neogen, expresó confianza en que la experiencia de Bernard proporcionará un valor significativo durante el continuo crecimiento de la empresa.
Bernard ha sido CEO de QIAGEN desde marzo de 2020, tras unirse a la compañía en 2015. Su experiencia previa incluye 15 años en bioMérieux SA, donde ocupó varios roles senior, incluyendo Vicepresidente Corporativo de Operaciones Comerciales Globales, Relaciones con Inversores y la Región de China Continental. Este nombramiento está en línea con el compromiso de Neogen de mejorar la seguridad alimentaria global.
Neogen (NASDAQ: NEOG)은 Thierry Bernard를 이사로 임명했다고 발표했으며, 임기는 2024년 11월 1일부터 시작된다. 현재 QIAGEN N.V.의 CEO인 Bernard는 Neogen의 시장과 관련된 과학 및 기술 분야에서 폭넓은 경험을 가지고 있다. Neogen의 이사장인 Jim Borel은 Bernard의 전문성이 회사의 지속적인 성장에 중요한 가치를 제공할 것이라고 확신한다고 밝혔다.
Bernard는 2015년에 회사에 합류한 이후 2020년 3월부터 QIAGEN의 CEO를 역임하고 있다. 그의 이전 경험으로는 bioMérieux SA에서 15년 동안 다양한 고위직을 역임했으며, 글로벌 상업 운영, 투자자 관계 및 중국 본토 지역의 부사장을 포함한다. 이번 임명은 Neogen의 글로벌 식량 안전 보장에 대한 헌신과 일치한다.
Neogen (NASDAQ: NEOG) a annoncé la nomination de Thierry Bernard en tant que nouveau directeur de son Conseil d'Administration, à compter du 1er novembre 2024. Bernard, actuel PDG de QIAGEN N.V., apporte une vaste expérience dans les sciences et les technologies pertinentes pour les marchés de Neogen. Jim Borel, président du Conseil d'Administration de Neogen, a exprimé sa confiance quant au fait que l'expertise de Bernard apportera une valeur significative durant la croissance continue de l'entreprise.
Bernard est PDG de QIAGEN depuis mars 2020, après avoir rejoint la société en 2015. Son expérience précédente comprend 15 ans chez bioMérieux SA, où il a occupé divers postes de direction, y compris Vice-Président pour les opérations commerciales mondiales, Relations investisseurs et la région Grande Chine. Cette nomination est en adéquation avec l'engagement de Neogen à améliorer la sécurité alimentaire mondiale.
Neogen (NASDAQ: NEOG) hat die Ernennung von Thierry Bernard als neuen Direktor des Vorstands bekannt gegeben, die am 1. November 2024 wirksam wird. Bernard, der derzeit CEO von QIAGEN N.V. ist, bringt umfangreiche Erfahrung in Wissenschaft und Technologien mit, die für die Märkte von Neogen relevant sind. Jim Borel, der Vorsitzende des Vorstands von Neogen, äußerte Vertrauen, dass Bernards Fachwissen während des fortlaufenden Wachstums des Unternehmens erheblichen Wert bieten wird.
Bernard ist seit März 2020 CEO von QIAGEN, nachdem er 2015 in das Unternehmen eingetreten ist. Zu seiner vorherigen Erfahrung gehören 15 Jahre bei bioMérieux SA, wo er verschiedene leitende Positionen innehatte, darunter Vizepräsident für globale Commercial-Operationen, Investor Relations und die Region Greater China. Diese Ernennung steht im Einklang mit Neogens Engagement für die Verbesserung der globalen Lebensmittelsicherheit.
- Appointment of an experienced industry leader to the Board of Directors
- New director brings relevant expertise in science and technologies
- Potential for valuable guidance during company's growth phase
- None.
"We are pleased to welcome Thierry Bernard to the Neogen Board of Directors and look forward to his guidance as the company continues in its commitment to fueling a brighter future for global food security," said Jim Borel, Neogen's Board Chair. "As a sitting CEO with a wealth of knowledge in science and technologies relevant to Neogen and its markets, we are confident that he will provide significant value to the Board during the company's continued growth."
Thierry Bernard is Chief Executive Officer of QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA), a leading global provider of sample-to-insight solutions that are used to transform biological materials into molecular insights. Mr. Bernard was named to the role in March 2020 after joining QIAGEN in 2015. Prior to his role at QIAGEN, Mr. Bernard spent 15 years with bioMérieux SA, where he held roles of increasing responsibility, most recently as Corporate Vice President, Global Commercial Operations, Investor Relations and the
About Neogen
Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.
Contact
PR@Neogen.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/neogen-announces-the-appointment-of-new-board-member-302263825.html
SOURCE Neogen Corporation
FAQ
Who is the new board member appointed to Neogen (NEOG)?
What is Thierry Bernard's background before joining Neogen's (NEOG) board?
When will Thierry Bernard join Neogen 's (NEOG) Board of Directors?
How does Neogen (NEOG) expect to benefit from Thierry Bernard's appointment?
